cylophosphamide in neuropsychiatric sle
DESCRIPTION
pharmacotherapyTRANSCRIPT
CYLOPHOSPHAMIDE IN NEUROPSYCHIATRIC SLE
ALGORITMA PENATALAKSANAAN SLE
Perhimpunan Rheumatologi Indonesia, 2011. Diagnosis dan Pengelolaan Lupus Eritematosus Sistemik. Rekomendasi Perhimpunan Rheumatologi Indonesia
Perhimpunan Rheumatologi Indonesia, 2011. Diagnosis dan Pengelolaan Lupus Eritematosus Sistemik. Rekomendasi Perhimpunan Rheumatologi Indonesia
Perhimpunan Rheumatologi Indonesia, 2011. Diagnosis dan Pengelolaan Lupus Eritematosus Sistemik. Rekomendasi Perhimpunan Rheumatologi Indonesia
Perhimpunan Rheumatologi Indonesia, 2011. Diagnosis dan Pengelolaan Lupus Eritematosus Sistemik. Rekomendasi Perhimpunan Rheumatologi Indonesia
Perhimpunan Rheumatologi Indonesia, 2011. Diagnosis dan Pengelolaan Lupus Eritematosus Sistemik. Rekomendasi Perhimpunan Rheumatologi Indonesia
– Cyclophosphamide given as monthly intravenous (500–1000mg/m2) doses for a six
month induction period followed by quarterly maintenance doses for a period of
two years
– Cyclophosphamide is a cytotoxic immunosuppressive treatment option with
documented therapeutic benefits in the management of severe NPSLE manifestations
unresponsive to other treatment modalities (nephritis and CNS manifestations)
Muscal, E & Brey, RL. 2011. Neurological Manifestations of Systemic Lupus Erythematosus in Children and Adults. NIH Public Access. Published in final edited form as:Neurol Clin. 2010 February
DAPUS
• Muscal, E & Brey, RL. 2011. Neurological Manifestations of Systemic Lupus Erythematosus in Children and Adults. NIH Public Access. Published in final edited form as: Neurol Clin. 2010 February
• Perhimpunan Rheumatologi Indonesia, 2011. Diagnosis dan Pengelolaan Lupus Eritematosus Sistemik. Rekomendasi Perhimpunan Rheumatologi Indonesia